Corporate ActionMay 8, 2026, 05:22 PM
Calidi Biotherapeutics Issues Warrant for 17.39M Shares at $0.23
AI Summary
Calidi Biotherapeutics, Inc. issued a warrant on May 6, 2026, to an accredited investor in a private placement. This warrant allows the purchase of up to 17,391,304 shares of common stock at an exercise price of $0.23, becoming first exercisable on September 8, 2026. The warrant's vesting is proportional to potential future issuances of up to $4.0 million in common stock, which may occur prior to July 8, 2026.
Key Highlights
- Calidi Biotherapeutics issued a warrant to an accredited investor on May 6, 2026.
- The warrant allows purchase of up to 17,391,304 unvested shares of common stock.
- The exercise price for the shares is $0.23.
- The warrant is first exercisable on September 8, 2026.
- The holder may acquire up to an aggregate of $4.0 million of Common Stock prior to July 8, 2026.
- The issuance was made in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b).
Price Impact
More from CLDI